Bibliography

Bibliography

Judson MA, Ghent S, Close TP. Sarcoidosis presenting as peripheral pulmonary infiltrates. JR1993;160:1359-1360.

Highland KB, Retalis P, Coppage L, Schabel SI, Judson MA. Is there an anatomical explanation for chest pain in patients with pulmonary sarcoidosis? Sou Med J 1997;90:911-914.

Judson MA. Lung transplantation for pulmonary sarcoidosis. Eur Respire J 1998; 11:738-744.

Judson MA, Strange, C. Bullous sarcoidosis: a report of three cases. Chest 1998; 114:1474-1478.

Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H, ACCESS Research Group. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. Sarcoidosis, Vasc, Diffuse Lung Dis 1999; 16:75-86

Marlow TJ, Krapiva PI, Schabel SI, Judson MA. The “fairy ring”: a new radiographic finding in sarcoidosis. Chest 1999;115:275-276

Judson MA. An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment. Chest 1999; 115:1158-1165Kajdasz DK, Judson MA, Mohr LC, Lackland DT. Geographic variation in the prevalence of sarcoidosis in South Carolina: its relationship to socioeconomic status and health care indicators. Am J Epidemiol 1999; 150:271-278

Niemer GW, Bolster MB, Buxbaum L, Judson MA. Carpal tunnel syndrome in sarcoidosis. Sarcoidosis, Vasc, Diffuse Lung Dis 2001; 18:296-30

Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager, Jr. H, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med (in press)

Rybicki B, Ianuzzi M, Frederick MM, Thompson B, Rossman M, Breznitz E, Teirstein A, Moeller D, Barnard J, Baughman RP, DePalo L, Hunninghake G, Johns C, Judson MA, et al. Familial aggregation of sarcoidosis: a case-control etiology study of sarcoidosis (ACCESS). Am J Respir Crit Care Med (in press)

Baughman RP, Ploysongsang Y, Roberts RD, Srivastava L. Effects of sarcoid and steroids on angiotensin-converting enzyme. Am Rev Respir Dis 1983; 128:631-633.
Baughman RP, Gerson M, Bosken CH. Right and left ventricular function at rest and with exercise in patients with sarcoidosis. Chest 1984; 85:301-306.
Baughman RP, Fernandez M, Bosken CH, Mantil J, Hurtubise P. Comparison of gallium-67 scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme levels in pulmonary sarcoidosis: predicting response to therapy. Am Rev Respir Dis 1984; 129:676-681.
Lower EE, Smith JT, Martelo OJ, Baughman RP. The anemia of sarcoidosis. Sarcoidosis 1988; 5:51-55.
Baughman RP, Strohofer SS, Buchsbaum J, Lower EE. Release of tumor necrosis factor by alveolar macrophages of sarcoid patients. J Lab Clin Med 1990; 115:36-42.
Lower EE, Baughman RP. The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci 1990; 229:153-157.
Baughman RP, Lower EE. The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis. Am Rev Respir Dis 1990; 142:1268-1271.
O’Brien GM, Baughman RP, Broderick JP, Arnold L, Lower EE. Paranoid psychosis due to neurosarcoidosis. Sarcoidosis 1994; 11:34-36.
Lower EE, Baughman RP. Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 1995; 155:846-851.
Turner GA, Lower EE, Corser BC, Gunther KL, Baughman RP. Sleep apnea in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14:61-64.
Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H Jr, and the ACCESS Research Group. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:75-86.
Lower EE, Broderick JP, Brott TG, Baughman RP. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997; 157:1864-1868.
Baughman RP, Winget DB, Bowen EH, Lower EE. Predicting respiratory failure in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14:154-158.
Rybicki BA, Maliarik MJ, Bock CH, Elston RC, Baughman RP, Kimani AP, Sheffer RG, Chen KM, Major M, Popovich J Jr, Iannuzzi MC. The Blau syndrome gene is not a major risk factor for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:203-208.
Baughman RP, Winget, DB, Lower EE. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17:60-66.
Zeitlin JF, Tami TA, Baughman RP, Winget DB. Nasal and sinus manifestations of sarcoidosis. Am J Rhinol 2000; 14:157-161.
Chang B, Steimel J, Moller DR, Baughman RP, Judson MA, Yeager H Jr, Teirstein AS, Rossman MD, Rand CS. Depression in sarcoidosis. Am J Respir Crit Care Med 2001; 163:329-334.
Baughman RP, Lower EE. Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18:70-74.
Lower EE, Hawkins HH, Baughman RP. Breast disease in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 301-305.
Baughman RP, Teirstein AS, Judson, MA, Rossman MD. Yeager H, Bresnitz EA, DePaulo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R. A Case Control Etiologic Study of Sarcoidosis (ACCESS) Research Group. Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis. Am J Respir Crit Care Med 2001; 164: 1885-1889.
Rybicki BA, Iannuzzi MC, Frederick MM, Thompson BW, Rossman MD, Bresnitz EA, Terrin ML, Moller DR, Barnard J, Baughman RP, DePaulo L, Hunninghake G, Johns CJ, Judson, MA, Knatterud GL, McLennan G, Newman LS, Rabin DL, Rose C, Teirstein AS, Weinberger SE, Yeager, Cherniak R, A Case Control Etiologic Study of Sarcoidosis (ACCESS) Research Group. Familial aggregation of sarcoidosis: a case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001; 164: 2085-2091.
Lower EE, Broderick JP, Brott TG, Baughman RP. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997; 157:1864-1868.
Baughman RP. Sarcoidosis: Usual and unusual manifestations. Chest 1988; 94:165-170.
Baughman RP, Lower EE, Lynch JP III. Treatment modalities for sarcoidosis. Clinical Pulmonary Medicine 1994; 223-231.
Baughman RP, Lower EE. Steroid-sparing alternative treatments for sarcoidosis. Clinics in Chest Medicine 1997; 18(4) 853-864
Baughman RP, Lower EE. Treatment of sarcoidosis with corticosteroids: who is going to relapse and why? Sarcoidosis Vasc Diffuse Lung Dis 1998; 15:19-20.
Lynch JP, Sharma OP, Baughman RP. Extrapulmonary sarcoidosis. Semin Resp Infect 1998; 13:229-254.
Baughman RP, Sharma OP, Lynch UP. Sarcoidosis: is therapy effective? Semin Resp Infect 1998; 13:255-273.
Lynch JP III, Baughman RP. When and how to use steroids for sarcoidosis. J Respir Dis 1998; 19(2):122-132.
Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax 1999; 54(8):742-746.
Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, Ecklund A, Kitaichi M, Lynch J, Rizzato G, Rose C, Selroos O, Semenzato G, Sharma OP. ATS/ERS/WASOG Statement on Sarcoidosis. Am J Resp Crit Care Med 1999; 160:736-755/Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:149-173.
Baughman RP, Ohmichi M, Lower EE. Combination therapy for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18:133-137.
Baughman RP. Sarcoidosis. In: Bone’s Atlas of Pulmonary and Critical Care Medicine. GD Campbell, DK Payne, Editors. 1999, Philadelphia, Current Medicine, Inc., pp 17.1 – 17.10.
Baughman RP, Alabo OF. Sarcoidosis. In: Conn’s Current Therapy 2001. RE Rakel, ET Bope, Editors. 2001, Philadelphia, WB Saunders Company, pp 237-240.
Baughman RP. Sarcoidosis. In: Bone’s Atlas of Pulmonary and Critical Care Medicine, Second Edition. GD Campbell, DK Payne, Editors. 2001, Philadelphia, Current Medicine, Inc., pp 201-210.
Book and Monograph Chapters
Judson MA. Extrapulmonary sarciodosis. Pulmonary and Critical Care Update 1999; 13(12):1-14